Pioglitazone improves endothelium-dependent vasodilation in hypertensive patients with impaired glucose tolerance in part through a decrease in oxidative stress

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 521-524

  Hidaka, Takayuki ^a   Nakagawa, Keigo ^a   Goto, Chikara ^a   Soga, Junko ^a   Fujii, Yuichi ^a   Hata, Takaki ^a   Idei, Naomi ^a   Fujimura, Noritaka ^a   Chayama, Kazuaki ^a   Kihara, Yasuki ^a   Higashi, Yukihito ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Endothelial function; Hypertension; Impaired glucose tolerance; Pioglitazone

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETYLCHOLINE; AMLODIPINE; NITROPRUSSIDE SODIUM; PIOGLITAZONE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ENDOTHELIUM; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MALE; MONOTHERAPY; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; VASODILATATION;

ACETYLCHOLINE; AGED; AMLODIPINE; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; NITROPRUSSIDE; OXIDATIVE STRESS; THIAZOLIDINEDIONES; VASODILATOR AGENTS;

EID: 77953229627     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.12.011     Document Type: Article

References (15)

1. Higashi Y., Oshima T., Sasaki N., et al. Relation between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension. Hypertension 1997, 29:280-285.
2. Celermajer D.S., Sorensen K.E., Bull C., Robinson J., Deanfield J.E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994, 24:1468-1474.
3. Pavo I., Jermendy G., Varkonyi T.T., et al. Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes. J Clin Endocrinol Metab 2003, 88:1637-1645.
4. Miyazaki Y., Mahankali A., Wajcberg E., et al. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2004, 89:4312-4319.
5. Spiegelman B.M. PPAR-gamma: adipogenic regulator and tiazolidinedione receptor. Diabetes 1998, 47:507-514.
6. Dormandy J.A., Charbonnel B., Eckland D.J., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005, 366:1279-1289.
7. Campia U., Matuskey L.A., Panza J.A. Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors. Circulation 2006, 113:867-875.
8. Wajcberg E., Sriwijitkamol A., Musi N., DeFronzo R.A., Cersosimo E. Relationship between vascular reactivity and lipids in Mexican-Americans with type 2 diabetes treated with pioglitazone. J Clin Endocrinol Metab 2007, 92:1256-1262.
9. Higashi Y., Sasaki S., Nakagawa K., et al. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002, 346:1954-1962.
10. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000, 87:840-844.
11. Taddei S., Virdis A., Ghiadoni L., Magagna A., Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998, 97:2222-2229.
12. Goya K., Sumitani S., Otsuki M., et al. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells. J Diab Complicat 2006, 20:336-342.
13. Cho D.H., Choi Y.J., Jo S.A., Jo I. Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone. J Biol Chem 2004, 279:2499-2506.
14. Huang P.H., Sata M., Nishimatsu H., et al. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice. Biomed Pharmacother 2008, 62:46-52.
15. Chen H., Montagnani M., Funahashi T., Shimomura I., Quon M.J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003, 278:45021-45026.